Ebralidze et al (1989) first introduced the association of S100A4 (mts 1) with metastatic capacity of tumour cells in their report that S100A4 mRNA expression level matched the metastatic potential of several tumour cell lines. The gene discussed is S100A4; the disease is neoplasm.